Publication | Closed Access

The opioid antagonist naltrexone inhibits activity and alters expression of α7 and α4β2 nicotinic receptors in hippocampal neurons: implications for smoking cessation programs

Tobacco ControlNeurophysiologyAddictionMedicinePhysiologyNicotineNeuropeptide ReceptorNeuropharmacologyAddiction MedicinePharmacotherapyNeuroscienceα4β2 Nicotinic ReceptorsPharmacologyNeurochemistryCessation ProgramsSocial SciencesOpioid Antagonist Naltrexone